Martha Kosinski
About Martha Kosinski
Martha Kosinski is the Executive Director of Worldwide Oncology Strategy at Bristol Myers Squibb, with extensive experience in life sciences consulting and commercial strategy development in oncology.
Education and Expertise
Martha Kosinski holds a Master of Business Administration (MBA) from Columbia Business School, earned from 2012 to 2014. She has also studied Economics as part of a study-abroad program at The London School of Economics and Political Science (LSE) in 2008, and completed her undergraduate studies in Pre-Med and Economics at Villanova University from 2005 to 2009. Her educational background provides a strong foundation in both business and economics, which complements her extensive experience in the life sciences and pharmaceutical industries.
Current Role at Bristol Myers Squibb
Martha Kosinski currently serves as the Executive Director, Worldwide Oncology Strategy at Bristol Myers Squibb. In this role, she leads the development of the strategic plan for the global oncology portfolio. Her responsibilities include steering the direction and growth of Bristol Myers Squibb's oncology initiatives, ensuring that the company maintains its competitive edge in the oncology sector.
Previous Positions at Bristol Myers Squibb
Before her current role, Kosinski was the US Commercial Strategy & Operations Lead at Bristol Myers Squibb from 2021 to 2022. She also served as the Renal Cell Carcinoma Lead for Opdivo & Yervoy in Worldwide Oncology Commercialization from 2020 to 2021. Her tenure at Bristol Myers Squibb has been marked by significant contributions, including the launch of several oncology products and the development of commercial strategies for renal cell carcinoma treatments.
Experience at L.E.K. Consulting
Martha Kosinski has substantial experience in the life sciences consulting sector, having worked at L.E.K. Consulting in various capacities. She served as an Engagement Manager in the Life Sciences Practice for five months in 2017, as a Senior Consultant from 2015 to 2016, and as a Consultant from 2014 to 2015. Additionally, she was a Summer Consultant in 2013. During her time at L.E.K. Consulting, she worked on numerous projects related to oncology and pharmaceuticals, enhancing her expertise in these fields.
Financial Analysis Roles at Quest Diagnostics
Prior to her roles in consulting and pharmaceuticals, Martha Kosinski worked at Quest Diagnostics. She was a Financial Analyst in Physician Finance from 2011 to 2012, and in Corporate Finance Planning & Analysis from 2009 to 2011. In these roles, she contributed to financial planning and analysis efforts, gaining valuable experience in the financial aspects of the healthcare industry.